If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMORE.L Regulatory News (MORE)

  • There is currently no data for MORE

Significant breakthrough with CHPDH plant

6 Dec 2016 07:00

RNS Number : 0251R
Cogenpower PLC
06 December 2016
 

 

Cogenpower plc

("Cogenpower" or "the Company")

 

Significant breakthrough with Cogenpower's CHPDH plant

 

Cogenpower (LSE: CGP), the AIM-quoted low-carbon technology energy business, is pleased to announce that with effect from December 2016 its Combined Heat and Power District Heating (CHPDH) power plant will be a wholly unmanned CHPDH plant, which means that all its operations will be fully automated through the Anaconda technology, a sophisticated Artificial Intelligence system. The positive financial impact resulting from cost savings will be reflected in the financial year ending 31 December 2017. At a divisional level, management anticipate savings in excess of €250,000 per annum.

 

Background to Anaconda technology

 

The Company's flagship plant in Borgaro Torinese, on the outskirts of Turin in the north of Italy, is a natural gas fuelled 3MWe (electrical output) / 15MWt (thermal output) CHPDH operation that serves approximately 4,600 end users in 63 separate buildings attached to a 13 kilometre pipe network. The operation is 92% energy efficient and consistently provides reduced CO2 emissions of about 3,000 tonnes per annum compared to traditional heating methods.

 

The energy efficiencies of the system are achieved through the Anaconda technology, an Artificial Intelligence system able to run a Combined Heat and Power Plant, a Heat Storage facility and a District Heating network all connected by a fibre optics infrastructure integrated within sophisticated algorithms and automation.

 

Company breakthrough

 

For the first time the Company is able to operate the CHPDH system, manage its billing services and credit collection activities without any staff. The breakthrough has been made possible by the Company's ability to combine operations and accounting effectively on the same digital platform.

 

Dr Francesco Vallone, founder and CEO of Cogenpower, said:

"This breakthrough is a significant step for Cogenpower following an extensive R&D programme to advance our unique technology, which clearly differentiates us from other systems. It will generate important efficiencies in any traditional CHPDH systems in which it is implemented, creating long-term value and driving a low-carbon energy business that ultimately does not have to rely on incentives to fund its growth."

 

-ENDS-

Further enquiries:

 

Cogenpower plc

Dr. Francesco Vallone

Martin Groak

Ilaria Cannata

 

+44 (0)20 7930 0777

 

Allenby Capital

(Nominated Adviser and Broker)

 

Nick Athanas

Richard Short

 

+44 (0)20 3328 5656

Cardew Group

Shan Shan Willenbrock

Nadja Vetter

Emma Ruttle

 

+44 (0)20 7930 0777

cogenpower@cardewgroup.com

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLELLBQLFZFBV
Date   Source Headline
7th Jun 20237:01 amRNSHolding(s) in Company
7th Jun 20237:00 amRNSAGM Trading Update
5th Jun 202311:03 amRNSIntended Purchase of Shares by CEO
5th Jun 20237:00 amRNSDirectorate Appointment
31st May 20239:57 amRNSDirector/PDMR Shareholding
17th May 20235:30 pmRNSDirector/PDMR Shareholding
17th May 202310:56 amRNSDirector/PDMR Shareholding
12th May 20235:29 pmRNSDirector/PDMR Shareholding
12th May 202311:58 amRNSHolding(s) in Company
10th May 20235:59 pmRNSHolding(s) in Company
3rd May 20236:29 pmRNSNotification of transactions by PDMR
2nd May 20237:00 amRNSCost Reduction Programme, CEO Appointment, Webcast
28th Apr 20236:23 pmRNSFinal Results
29th Mar 20231:25 pmRNSHolding(s) in Company
14th Mar 20234:24 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSRevised Results Publication Date & Trading Update
27th Feb 20234:35 pmRNSPrice Monitoring Extension
24th Feb 20234:35 pmRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSDirectorate Change
10th Jan 20237:00 amRNSTrading Update and Board Change
19th Dec 20226:16 pmRNSDirectorate Change
16th Dec 20229:17 amRNSHolding(s) in Company
13th Dec 20225:53 pmRNSDirectorate Change
8th Dec 202210:00 amRNSDirector/PDMR Shareholding
29th Nov 202211:24 amRNSHolding(s) in Company
29th Nov 202210:38 amRNSDirector/PDMR Shareholding
9th Nov 20227:00 amRNSLaunch of major new marketing campaign
8th Nov 202210:38 amRNSHolding(s) in Company
18th Oct 20224:40 pmRNSSecond Price Monitoring Extn
18th Oct 20224:35 pmRNSPrice Monitoring Extension
30th Sep 20223:28 pmRNSDirector/PDMR Shareholding
27th Sep 20226:31 pmRNSDirector/PDMR Shareholding
26th Sep 20226:28 pmRNSHolding(s) in Company
26th Sep 20225:35 pmRNSHolding(s) in Company
26th Sep 20227:30 amRNSDirector/PDMR Shareholding
23rd Sep 202212:56 pmRNSHolding(s) in Company
22nd Sep 20224:02 pmRNSDirector/PDMR Shareholding
22nd Sep 20229:09 amRNSDirector/PDMR Shareholding
21st Sep 20227:00 amRNSInterim Results
12th Sep 20223:45 pmRNSNotice of Interim Results - Update
30th Aug 20221:02 pmRNSNotice of Interim Results
26th Aug 20229:58 amRNSHolding(s) in Company
25th Aug 20225:08 pmRNSHolding(s) in Company
23rd Aug 20221:55 pmRNSHolding(s) in Company
16th Aug 20229:38 amRNSDirectorate Change
21st Jul 202210:40 amRNSPurchase of Shares by EBT
11th Jul 20225:22 pmRNSHolding(s) in Company - Amendment (1 July 2022)
11th Jul 20227:00 amRNSTrading update for the 26 weeks ended 3 July 2022
1st Jul 20222:54 pmRNSHolding(s) in Company
30th Jun 20225:25 pmRNSIntended Purchase of Shares by EBT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.